' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID


Gewähltes Keyword: refractory

Age-related MR characteristics in mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy (MOGHE).
Hartlieb, T; Winkler, P; Coras, R; Pieper, T; Holthausen, H; Blümcke, I; Staudt, M; Kudernatsch, M;
Epilepsy Behav. 2019; 91:68-74
Originalarbeiten (Zeitschrift)
Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.
Huemer, F; Melchardt, T; Jansko, B; Wahida, A; Jilg, S; Jost, PJ; Klieser, E; Katja, S; Magnes, T; Pleyer, L; Greil-Ressler, S; Rass, C; Greil, R; Egle, A;
Eur J Haematol. 2019; 102(5):437-441
Plitidepsin: a potential new treatment for relapsed/refractory multiple myeloma.
Leisch, M; Egle, A; Greil, R;
Future Oncol. 2019; 15(2):109-120
Originalarbeiten (Zeitschrift)
Blood markers of cardiac stress after generalized convulsive seizures.
Nass, RD; Motloch, LJ; Paar, V; Lichtenauer, M; Baumann, J; Zur, B; Hoppe, UC; Holdenrieder, S; Elger, CE; Surges, R;
Epilepsia. 2019; 60(2):201-210
Originalarbeiten (Zeitschrift)
Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain.
Strzelczyk, A; Knake, S; Kälviäinen, R; Santamarina, E; Toledo, M; Willig, S; Rohracher, A; Trinka, E; Rosenow, F;
Acta Neurol Scand. 2019; 139(4):369-376
Originalarbeiten (Zeitschrift)
PRUNE1 Deficiency: Expanding the Clinical and Genetic Spectrum.
Alhaddad, B; Schossig, A; Haack, TB; Kovács-Nagy, R; Braunisch, MC; Makowski, C; Senderek, J; Vill, K; Müller-Felber, W; Strom, TM; Krabichler, B; Freisinger, P; Deshpande, C; Polster, T; Wolf, NI; Desguerre, I; Wörmann, F; Rötig, A; Ahting, U; Kopajtich, R; Prokisch, H; Meitinger, T; Feichtinger, RG; Mayr, JA; Jungbluth, H; Hubmann, M; Zschocke, J; Distelmaier, F; Koch, J;
Neuropediatrics. 2018; 49(5):330-338
Originalarbeiten (Zeitschrift)
Etiologies and characteristics of refractory status epilepticus cases in different areas of the world: Results from a global audit.
Ferlisi, M; Hocker, S; Trinka, E; Shorvon, S;
Epilepsia. 2018; 59 Suppl 2: 100-107.
Originalarbeiten (Zeitschrift)
Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions
Hirsch, LJ; Gaspard, N; van Baalen, A; Nabbout, R; Demeret, S; Loddenkemper, T; Navarro, V; Specchio, N; Lagae, L; Rossetti, AO; Hocker, S; Gofton, TE; Abend, NS; Gilmore, EJ; Hahn, C; Khosravani, H; Rosenow, F; Trinka, E
EPILEPSIA. 2018; 59(4): 739-744.
Intravenous ketamine in status epilepticus.
Höfler, J; Trinka, E;
Epilepsia. 2018; 59 Suppl 2: 198-206.
Originalarbeiten (Zeitschrift)
SENSE registry for status epilepticus.
Kellinghaus, C; Rossetti, AO; Trinka, E; Lang, N; Unterberger, I; Rüegg, S; Tilz, C; Uzelac, Z; Rosenow, F;
Epilepsia. 2018; 59 Suppl 2: 150-154.
Influence of titration schedule and maintenance dose on the tolerability of adjunctive eslicarbazepine acetate: An integrated analysis of three randomized placebo-controlled trials.
Krauss, G; Biton, V; Harvey, JH; Elger, C; Trinka, E; Soares da Silva, P; Gama, H; Cheng, H; Grinnell, T; Blum, D;
Epilepsy Res. 2018; 139:1-8
Originalarbeiten (Zeitschrift)
Benefit of magnetic source localization in challenging refractory epilepsies
Kreidenhuber, R; Demarchi, G; Kalss, G; Leitinger, M; Winkler, PA; Trinka, E; Rampp, S
Z EPILEPTOL. 2018; 31(3): 179-184.
Originalarbeiten (Zeitschrift)
S100B, Homocysteine, Vitamin B12, Folic Acid, and Procalcitonin Serum Levels in Remitters to Electroconvulsive Therapy: A Pilot Study.
Maier, H; Helm, S; Toto, S; Moschny, N; Sperling, W; Hillemacher, T; Kahl, KG; Jakubovski, E; Bleich, S; Frieling, H; Neyazi, A;
Dis Markers. 2018; 2018: 2358451
Originalarbeiten (Zeitschrift)
Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit: A single-center audit of 30 patients.
Rohracher, A; Kalss, G; Neuray, C; Höfler, J; Dobesberger, J; Kuchukhidze, G; Kreidenhuber, R; Florea, C; Thomschewski, A; Novak, HF; Pilz, G; Leitinger, M; Trinka, E;
Epilepsia. 2018; 59 Suppl 2: 234-242.
Originalarbeiten (Zeitschrift)
Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trials.
Biton, V; Rogin, JB; Krauss, G; Abou-Khalil, B; Rocha, JF; Moreira, J; Gama, H; Trinka, E; Elger, CE; Cheng, HL; Grinnell, T; Blum, D
Epilepsy Behav. 2017; 72:127-134
Originalarbeiten (Zeitschrift)
Topiramate in the Treatment of Generalized Convulsive Status Epilepticus in Adults: A Systematic Review with Individual Patient Data Analysis.
Brigo, F; Bragazzi, NL; Igwe, SC; Nardone, R; Trinka, E
DRUGS. 2017; 77(1): 67-74.
Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
Brissot, E; Labopin, M; Stelljes, M; Ehninger, G; Schwerdtfeger, R; Finke, J; Kolb, HJ; Ganser, A; Schafer-Eckart, K; Zander, AR; Bunjes, D; Mielke, S; Bethge, WA; Milpied, N; Kalhs, P; Blau, IW; Kroger, N; Vitek, A; Gramatzki, M; Holler, E; Schmid, C; Esteve, J; Mohty, M; Nagler, A
J HEMATOL ONCOL. 2017; 10(1): 130
Originalarbeiten (Zeitschrift)
Pooled efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Data from four double-blind placebo-controlled pivotal phase III clinical studies.
Elger, C; Koepp, M; Trinka, E; Villanueva, V; Chaves, J; Ben-Menachen, E; Kowacs, PA; Gil-Nagel, A; Moreira, J; Gama, H; Rocha, JF; Soares-da-Silva, P
CNS NEUROSCI THER. 2017; 23(12): 961-972.
Originalarbeiten (Zeitschrift)
Mortality, morbidity and refractoriness prediction in status epilepticus: Comparison of STESS and EMSE scores.
Giovannini, G; Monti, G; Tondelli, M; Marudi, A; Valzania, F; Leitinger, M; Trinka, E; Meletti, S;
Seizure. 2017; 46: 31-37.
Originalarbeiten (Zeitschrift)
Biofilm formation of the black yeast-like fungus Exophiala dermatitidis and its susceptibility to antiinfective agents.
Kirchhoff, L; Olsowski, M; Zilmans, K; Dittmer, S; Haase, G; Sedlacek, L; Steinmann, E; Buer, J; Rath, PM; Steinmann, J;
Sci Rep. 2017; 7: 42886
Originalarbeiten (Zeitschrift)
Microcystic adnexal carcinoma (MAC)-like squamous cell carcinoma as a differential diagnosis to Bell´s palsy: review of guidelines for refractory facial nerve palsy.
Mueller, SK; Iro, H; Lell, M; Seifert, F; Bohr, C; Scherl, C; Agaimy, A; Traxdorf, M;
J Otolaryngol Head Neck Surg. 2017; 46(1): 1
Refractory plasmablastic lymphoma-a review of treatment options beyond standard therapy.
Pretscher, D; Kalisch, A; Wilhelm, M; Birkmann, J;
Ann Hematol. 2017; 96(6):967-970
The first meeting of the Austrian Expert Panel for Molecular Cancer Profiling
Seeber, A; Gastl, G; Eisterer, W; Gampenrieder, SP; Gerger, A; Kieler, M; Pichler, M; Prager, GW; Untergasser, G; Weltermann, A; Greil, R
MEMO-MAG EUR MED ONC. 2017; 10(4): 255-258.
Originalarbeiten (Zeitschrift)
25 years of advances in the definition, classification and treatment of status epilepticus.
Trinka, E; Kälviäinen, R;
Seizure. 2017; 44:65-73
Originalarbeiten (Zeitschrift)
Febrile Infection-Related Epilepsy Syndrome: Clinical Review and Hypotheses of Epileptogenesis.
van Baalen, A; Vezzani, A; Häusler, M; Kluger, G;
Neuropediatrics. 2017; 48(1):5-18
Originalarbeiten (Zeitschrift)
Current standards of neuropsychological assessment in epilepsy surgery centers across Europe.
Vogt, VL; Äikiä, M; Del Barrio, A; Boon, P; Borbély, C; Bran, E; Braun, K; Carette, E; Clark, M; Cross, JH; Dimova, P; Fabo, D; Foroglou, N; Francione, S; Gersamia, A; Gil-Nagel, A; Guekht, A; Harrison, S; Hecimovic, H; Heminghyt, E; Hirsch, E; Javurkova, A; Kälviäinen, R; Kavan, N; Kelemen, A; Kimiskidis, VK; Kirschner, M; Kleitz, C; Kobulashvili, T; Kosmidis, MH; Kurtish, SY; Lesourd, M; Ljunggren, S; Lossius, MI; Malmgren, K; Mameniskiené, R; Martin-Sanfilippo, P; Marusic, P; Miatton, M; Özkara, Ç; Pelle, F; Rubboli, G; Rudebeck, S; Ryvlin, P; van Schooneveld, M; Schmid, E; Schmidt, PM; Seeck, M; Steinhoff, BJ; Shavel-Jessop, S; Tarta-Arsene, O; Trinka, E; Viggedal, G; Wendling, AS; Witt, JA; Helmstaedter, C;
Epilepsia. 2017; 58(3): 34-355.
Originalarbeiten (Zeitschrift)
Surgical Myectomy after Failed Ablation for Hypertrophic Obstructive Cardiomyopathy.
Bougioukas, I; Hoppe, U; Danner, B; Schoendube, FA;
Thorac Cardiovasc Surg Rep. 2016; 5(1): 30-32.
(S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study.
Höfler, J; Rohracher, A; Kalss, G; Zimmermann, G; Dobesberger, J; Pilz, G; Leitinger, M; Kuchukhidze, G; Butz, K; Taylor, A; Novak, H; Trinka, E;
CNS Drugs. 2016; 30(9):869-876
Originalarbeiten (Zeitschrift)
An international, multicenter, prospective, observational study of neutropenia in patients being treated with lenalidomide + dexamethasone for relapsed or relapsed/refractory multiple myeloma (RR-MM).
Leleu, X; Terpos, E; Sanz, RG; Cooney, J; OGorman, P; Minarik, J; Greil, R; Williams, C; Gray, D; Szabo, Z;
Am J Hematol. 2016; 91(8):806-811
Originalarbeiten (Zeitschrift)
GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers.
Li, D; Yuan, HJ; Ortiz-Gonzalez, XR; Marsh, ED; Tian, LF; McCormick, EM; Kosobucki, GJ; Chen, WJ; Schulien, AJ; Chiavacci, R; Tankovic, A; Naase, C; Brueckner, F; von Stulpnagel-Steinbeis, C; Hu, C; Kusumoto, H; Hedrich, UBS; Elsen, G; Hortnagel, K; Aizenman, E; Lemke, JR; Hakonarson, H; Traynelis, SF; Falk, MJ
AM J HUM GENET. 2016; 99(4): 802-816.
Originalarbeiten (Zeitschrift)
Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance.
Mebazaa, A; Tolppanen, H; Mueller, C; Lassus, J; DiSomma, S; Baksyte, G; Cecconi, M; Choi, DJ; Cohen Solal, A; Christ, M; Masip, J; Arrigo, M; Nouira, S; Ojji, D; Peacock, F; Richards, M; Sato, N; Sliwa, K; Spinar, J; Thiele, H; Yilmaz, MB; Januzzi, J;
Intensive Care Med. 2016; 42(2): 147-163.
Originalarbeiten (Zeitschrift)
Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.
Melchardt, T; Hufnagl, C; Weinstock, DM; Kopp, N; Neureiter, D; Tränkenschuh, W; Hackl, H; Weiss, L; Rinnerthaler, G; Hartmann, TN; Greil, R; Weigert, O; Egle, A;
Oncotarget. 2016; 7(32):51494-51502
Originalarbeiten (Zeitschrift)
[Standardisation of the Initial Treatment of Severely Burned Patients: The Necessary Transfer of Concepts from Trauma Care].
Münzberg, M; Harbers, T; Kneser, U; Grützner, PA; Reichert, B; Kremer, T; Wölfl, CG; Horter, J; Hirche, C;
Zentralbl Chir. 2016; 141(6):654-659
Originalarbeiten (Zeitschrift)
[Transitional fractures : Epiphyseal injuries in adolescence].
Schneidmueller, D; von Rüden, C; Friederichs, J; Bühren, V;
Unfallchirurg. 2016; 119(6): 517-526.
Originalarbeiten (Zeitschrift)
Recent advances in status epilepticus.
Trinka, E; Brigo, F; Shorvon, S;
Curr Opin Neurol. 2016; 29(2): 189-198.
Originalarbeiten (Zeitschrift)
Pharmacologic treatment of status epilepticus.
Trinka, E; Höfler, J; Leitinger, M; Rohracher, A; Kalss, G; Brigo, F;
Expert Opin Pharmacother. 2016; 17(4):51-34
Originalarbeiten (Zeitschrift)
Perampanel for focal epilepsy: insights from early clinical experience.
Trinka, E; Steinhoff, BJ; Nikanorova, M; Brodie, MJ;
Acta Neurol Scand. 2016; 133(3): 160-172.
Long-term intravenous inotropes in low-output terminal heart failure?
von Scheidt, W; Pauschinger, M; Ertl, G
Clin Res Cardiol. 2016; 105(6):471-481
Originalarbeiten (Zeitschrift)
Low Beclin-1 expression predicts improved overall survival in patients treated with immunomodulatory drugs for multiple myeloma and identifies autophagy inhibition as a promising potentially druggable new therapeutic target: an analysis from The Austrian Myeloma Registry (AMR).
Willenbacher, W; Thangavadivel, S; Greil, R; Willenbacher, E; Weger, R; Manzl, C; Jöhrer, K; Brunner, A;
Leuk Lymphoma. 2016; 57(10):2330-2341
Originalarbeiten (Zeitschrift)
Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies: first experiences.
Biro, A; Stephani, U; Tarallo, T; Bast, T; Schlachter, K; Fleger, M; Kurlemann, G; Fiedler, B; Leiz, S; Nikanorova, M; Wolff, M; Muller, A; Selch, C; Staudt, M; Kluger, G
NEUROPEDIATRICS. 2015; 46(2): 110-115.
Originalarbeiten (Zeitschrift)
Preliminary results of the global audit of treatment of refractory status epilepticus.
Ferlisi, M; Hocker, S; Grade, M; Trinka, E; Shorvon, S
Epilepsy Behav. 2015; 49:318-324
Originalarbeiten (Zeitschrift)
Supraciliary Micro-stent Implantation for Open-Angle Glaucoma Failing Topical Therapy: 1-Year Results of a Multicenter Study.
García-Feijoo, J; Rau, M; Grisanti, S; Grisanti, S; Höh, H; Erb, C; Guguchkova, P; Ahmed, I; Grabner, G; Reitsamer, H; Shaarawy, T; Ianchulev, T;
Am J Ophthalmol. 2015; 159(6):1075-1081.e1
Originalarbeiten (Zeitschrift)
Mortality and SUDEP in epilepsy patients treated with vagus nerve stimulation
Granbichler, CA; Nashef, L; Selway, R; Polkey, CE
EPILEPSIA. 2015; 56(2): 291-296.
Originalarbeiten (Zeitschrift)
Hemispherectomy for treatment of refractory epilepsy in the pediatric age group: a systematic review.
Griessenauer, CJ; Salam, S; Hendrix, P; Patel, DM; Tubbs, RS; Blount, JP; Winkler, PA;
J NEUROSURG-PEDIATR. 2015; 15(1): 3-44.
Originalarbeiten (Zeitschrift)
High-frequency oscillations in epilepsy and surgical outcome. A meta-analysis.
Holler, Y; Kutil, R; Klaffenbock, L; Thomschewski, A; Holler, PM; Bathke, AC; Jacobs, J; Taylor, AC; Nardone, R; Trinka, E
FRONT HUM NEUROSCI. 2015; 9: 574
Originalarbeiten (Zeitschrift)
Making SENSE--Sustained Effort Network for treatment of Status Epilepticus as a multicenter prospective registry.
Kellinghaus, C; Lang, N; Rossetti, AO; Ruegg, S; Tilz, C; Trinka, E; Unterberger, I; Uzelac, Z; Rosenow, F
BMC NEUROL. 2015; 15: 230
Originalarbeiten (Zeitschrift)
The phenotypic spectrum of SCN8A encephalopathy.
Larsen, J; Carvill, GL; Gardella, E; Kluger, G; Schmiedel, G; Barisic, N; Depienne, C; Brilstra, E; Mang, Y; Nielsen, JE; Kirkpatrick, M; Goudie, D; Goldman, R; Jähn, JA; Jepsen, B; Gill, D; Döcker, M; Biskup, S; McMahon, JM; Koeleman, B; Harris, M; Braun, K; de Kovel, CG; Marini, C; Specchio, N; Djémié, T; Weckhuysen, S; Tommerup, N; Troncoso, M; Troncoso, L; Bevot, A; Wolff, M; Hjalgrim, H; Guerrini, R; Scheffer, IE; Mefford, HC; Møller, RS;
Neurology. 2015; 84(5): 480-489.
Originalarbeiten (Zeitschrift)
[Therapie des Patienten mit Radioiod-refraktärem, differenziertem Schilddrüsenkarzinom. Ein Konsensusstatement].
Lindner, C; Dierneder, J; Pall, G; Pirich, C; Hoffmann, M; Raderer, M; Becherer, A; Niederle, B; Lipp, R; Lind, P; Gallowitsch, H; Romeder, F; Virgolini, I;
Nuklearmedizin. 2015; 54(3): 125-130.
Originalarbeiten (Zeitschrift)
Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit.
Rohracher, A; Hofler, J; Kalss, G; Leitinger, M; Kuchukhidze, G; Deak, I; Dobesberger, J; Novak, H; Pilz, G; Zerbs, A; Trinka, E
EPILEPSY BEHAV. 2015; 49: 354-358.
Originalarbeiten (Zeitschrift)
Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer.
Stintzing, S; Zhang, W; Heinemann, V; Neureiter, D; Kemmerling, R; Kirchner, T; Jung, A; Folwaczny, M; Yang, D; Ning, Y; Sebio, A; Stremitzer, S; Sunakawa, Y; Matsusaka, S; Yamauchi, S; Loupakis, F; Cremolini, C; Falcone, A; Lenz, HJ;
Mol Cancer Ther. 2015; 14(10): 2374-2381.
Originalarbeiten (Zeitschrift)
Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML-long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL)†.
Thiel, A; Schetelig, J; Pönisch, W; Schäfer-Eckart, K; Aulitzky, W; Peter, N; Schulze, A; Maschmeyer, G; Neugebauer, S; Herbst, R; Hänel, A; Morgner, A; Kroschinsky, F; Bornhäuser, M; Lange, T; Wilhelm, M; Niederwieser, D; Ehninger, G; Fiedler, F; Hänel, M;
Ann Oncol. 2015; 26(7): 143-140.
Originalarbeiten (Zeitschrift)
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
Byrd, JC; Brown, JR; O"Brien, S; Barrientos, JC; Kay, NE; Reddy, NM; Coutre, S; Tam, CS; Mulligan, SP; Jaeger, U; Devereux, S; Barr, PM; Furman, RR; Kipps, TJ; Cymbalista, F; Pocock, C; Thornton, P; Caligaris-Cappio, F; Robak, T; Delgado, J; Schuster, SJ; Montillo, M; Schuh, A; de Vos, S; Gill, D; Bloor, A; Dearden, C; Moreno, C; Jones, JJ; Chu, AD; Fardis, M; McGreivy, J; Clow, F; James, DF; Hillmen, P;
N Engl J Med. 2014; 371(3): 213-223.
Originalarbeiten (Zeitschrift)
Transition issues for children with diffuse cortical malformations, multifocal postnatal lesions, (infectious and traumatic) and Lennox-Gastaut and similar syndromes.
Camfield, PR; Bahi-Buisson, N; Trinka, E
EPILEPSIA. 2014; 55 Suppl 3: 24-28.
Originalarbeiten (Zeitschrift)
Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses.
Coiffier, B; Pro, B; Prince, HM; Foss, F; Sokol, L; Greenwood, M; Caballero, D; Morschhauser, F; Wilhelm, M; Pinter-Brown, L; Iyer, SP; Shustov, A; Nielsen, T; Nichols, J; Wolfson, J; Balser, B; Horwitz, S
J Hematol Oncol. 2014; 7:11
Originalarbeiten (Zeitschrift)
Fulminant systemic capillary leak syndrome due to C1 inhibitor deficiency complicating acute dermatomyositis: a case report.
Gradwohl-Matis, I; Illig, R; Salmhofer, H; Neureiter, D; Brunauer, A; Dünser, MW;
J Med Case Rep. 2014; 8:28
Originalarbeiten (Zeitschrift)
Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.
Hopfinger, G; Nösslinger, T; Lang, A; Linkesch, W; Melchardt, T; Weiss, L; Egle, A; Greil, R;
Ann Hematol. 2014; 93(3):459-462
Originalarbeiten (Zeitschrift)
The consequences of refractory epilepsy and its treatment
Laxer, KD; Trinka, E; Hirsch, LJ; Cendes, F; Langfitt, J; Delanty, N; Resnick, T; Benbadis, SR
EPILEPSY BEHAV. 2014; 37: 59-70.
Epilepsy in Aicardi-Goutières syndrome.
Ramantani, G; Maillard, LG; Bast, T; Husain, RA; Niggemann, P; Kohlhase, J; Hertzberg, C; Ungerath, K; Innes, MA; Walkenhorst, H; Bevot, A; von Stülpnagel, C; Thomas, K; Niemann, F; Ergun, MA; Tacke, U; Häusler, M; Ikonomidou, C; Korinthenberg, R; Lee-Kirsch, MA;
Eur J Paediatr Neurol. 2014; 18(1): 30-37.
Originalarbeiten (Zeitschrift)
[Quality guidelines for presurgical epilepsy diagnosis and operative epilepsy therapy : 1st revised version].
Rosenow, F; Bast, T; Czech, T; Hans, V; Helmstaedter, C; Huppertz, HJ; Seeck, M; Trinka, E; Wagner, K;
Nervenarzt. 2014; 85(6): 753-756.
Originalarbeiten (Zeitschrift)
[Dialysis and ultrafiltration therapy in patients with cardio-renal syndrome: recommendations of the working group "heart-kidney" of the German Cardiac Society and the German Society of Nephrology].
Schwenger, V; Remppis, BA; Westenfeld, R; Weinreich, T; Brunkhorst, R; Schieren, G; Krumme, B; Haller, H; Schmieder, R; Schlieper, G; Frye, B; Hoppe, UC; Hoyer, J; Keller, T; Blumenstein, M; Schunkert, H; Mahfoud, F; Rump, LC
DEUT MED WOCHENSCHR. 2014; 139(7): e1-e8.
Intravenous sildenafil i.v. as rescue treatment for refractory pulmonary hypertension in extremely preterm infants.
Steiner, M; Salzer, U; Baumgartner, S; Waldhoer, T; Klebermass-Schrehof, K; Wald, M; Langgartner, M; Berger, A;
Klin Padiatr. 2014; 226(4):211-215
Originalarbeiten (Zeitschrift)
Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells.
Wilhelm, M; Smetak, M; Schaefer-Eckart, K; Kimmel, B; Birkmann, J; Einsele, H; Kunzmann, V
J Transl Med. 2014; 12:45
Originalarbeiten (Zeitschrift)
Infections in status epilepticus: A retrospective 5-year cohort study.
Zelano, J; Möller, F; Dobesberger, J; Trinka, E; Kumlien, E;
Seizure. 2014; 23(8): 603-606.
Originalarbeiten (Zeitschrift)
Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.
Beheshti, M; Haim, S; Zakavi, R; Steinmair, M; Waldenberger, P; Kunit, T; Nader, M; Langsteger, W; Loidl, W;
J Nucl Med. 2013; 54(6): 833-840.
Originalarbeiten (Zeitschrift)
The established status epilepticus trial 2013.
Bleck, T; Cock, H; Chamberlain, J; Cloyd, J; Connor, J; Elm, J; Fountain, N; Jones, E; Lowenstein, D; Shinnar, S; Silbergleit, R; Treiman, D; Trinka, E; Kapur, J;
Epilepsia. 2013; 54 Suppl 6: 89-92.
Originalarbeiten (Zeitschrift)
Rufinamide for refractory focal seizures: an open-label, multicenter European study.
Coppola, G; Zamponi, N; Kluger, G; Mueller, A; Anna Rita, M; Parisi, P; Isone, C; Santoro, E; Curatolo, P; Verrotti, A;
Seizure. 2013; 22(1): 33-36.
Originalarbeiten (Zeitschrift)
Lacosamide as a new treatment option in status epilepticus.
Höfler, J; Trinka, E;
Epilepsia. 2013; 54(3):393-404
Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.
Hopfinger, G; Busch, R; Pflug, N; Weit, N; Westermann, A; Fink, AM; Cramer, P; Reinart, N; Winkler, D; Fingerle-Rowson, G; Stilgenbauer, S; Döhner, H; Kandler, G; Eichhorst, B; Hallek, M; Herling, M;
Cancer. 2013; 119(12):2258-2267
Originalarbeiten (Zeitschrift)
Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings.
Kubicka, S; Greil, R; André, T; Bennouna, J; Sastre, J; Van Cutsem, E; von Moos, R; Osterlund, P; Reyes-Rivera, I; Müller, T; Makrutzki, M; Arnold, D;
Ann Oncol. 2013; 24(9):2342-2349
Originalarbeiten (Zeitschrift)
[Status epilepticus].
Feddersen, B; Trinka, E;
Nervenarzt. 2012; 83(2): 187-194.
Originalarbeiten (Zeitschrift)
An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy.
Grünwald, V; Karakiewicz, PI; Bavbek, SE; Miller, K; Machiels, JP; Lee, SH; Larkin, J; Bono, P; Rha, SY; Castellano, D; Blank, CU; Knox, JJ; Hawkins, R; Anak, O; Rosamilia, M; Booth, J; Pirotta, N; Bodrogi, I;
Eur J Cancer. 2012; 48(3): 324-332.
Originalarbeiten (Zeitschrift)
Candidate gene sequencing of SLC11A2 and TMPRSS6 in a family with severe anaemia: common SNPs, rare haplotypes, no causative mutation.
Kloss-Brandstätter, A; Erhart, G; Lamina, C; Meister, B; Haun, M; Coassin, S; Seifert, M; Klein-Franke, A; Paulweber, B; Kedenko, L; Kollerits, B; Swinkels, DW; Vermeulen, SH; Galesloot, TE; Kronenberg, F; Weiss, G;
PLoS One. 2012; 7(4): e35015
Originalarbeiten (Zeitschrift)
PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas
Laimer, D; Dolznig, H; Kollmann, K; Vesely, PW; Schlederer, M; Merkel, O; Schiefer, AI; Hassler, MR; Heider, S; Amenitsch, L; Thallinger, C; Staber, PB; Simonitsch-Klupp, I; Artaker, M; Lagger, S; Turner, SD; Pileri, S; Piccaluga, PP; Valent, P; Messana, K; Landra, I; Weichhart, T; Knapp, S; Shehata, M; Todaro, M; Sexl, V; Hofler, G; Piva, R; Medico, E; Ruggeri, BA; Cheng, MG; Eferl, R; Egger, G; Penninger, JM; Jaeger, U; Moriggl, R; Inghirami, G; Kenner, L
NAT MED. 2012; 18(11): 1699-+.
Immunoadsorption in dermatology.
Meyersburg, D; Schmidt, E; Kasperkiewicz, M; Zillikens, D;
Ther Apher Dial. 2012; 16(4):311-320
Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases.
Rick, FG; Schally, AV; Szalontay, L; Block, NL; Szepeshazi, K; Nadji, M; Zarandi, M; Hohla, F; Buchholz, S; Seitz, S;
Proc Natl Acad Sci U S A. 2012; 109(5):1655-1660
Originalarbeiten (Zeitschrift)
Hemodiafiltration in infants with complications during peritoneal dialysis.
Rodl, S; Marschitz, I; Mache, CJ; Nagel, B; Koestenberger, M; Zobel, G
Artif Organs. 2012; 36(7):590-593
Originalarbeiten (Zeitschrift)
Seizures and epilepsy in herpes simplex virus encephalitis: current concepts and future directions of pathogenesis and management.
Sellner, J; Trinka, E;
J Neurol. 2012; 259(10): 2019-2030.
[Renal sympathetic denervation. A novel interventional treatment option for therapy-resistant arterial hypertension].
Brandt, MC; Mahfoud, F; Böhm, M; Hoppe, UC;
Herz. 2011; 36(1): 8-11.
Video-EEG monitoring: safety and adverse events in 507 consecutive patients.
Dobesberger, J; Walser, G; Unterberger, I; Seppi, K; Kuchukhidze, G; Larch, J; Bauer, G; Bodner, T; Falkenstetter, T; Ortler, M; Luef, G; Trinka, E;
Epilepsia. 2011; 52(3):443-452
Originalarbeiten (Zeitschrift)
Intravenous lacosamide in status epilepticus and seizure clusters.
Höfler, J; Unterberger, I; Dobesberger, J; Kuchukhidze, G; Walser, G; Trinka, E;
Epilepsia. 2011; 52(10): e148-e152.
Originalarbeiten (Zeitschrift)
Febrile infection-related epilepsy syndrome (FIRES): Does duration of anesthesia affect outcome?
Kramer, U; Chi, CS; Lin, KL; Specchio, N; Sahin, M; Olson, H; Kluger, G; van Baalen, A
EPILEPSIA. 2011; 52: 28-30.
Originalarbeiten (Zeitschrift)
Febrile infection-related epilepsy syndrome (FIRES): Pathogenesis, treatment, and outcome A multicenter study on 77 children
Kramer, U; Chi, CS; Lin, KL; Specchio, N; Sahin, M; Olson, H; Nabbout, R; Kluger, G; Lin, JJ; van Baalen, A
EPILEPSIA. 2011; 52(11): 1956-1965.
Originalarbeiten (Zeitschrift)
Low long-term efficacy and tolerability of add-on rufinamide in patients with Dravet syndrome
Mueller, A; Boor, R; Coppola, G; Striano, P; Dahlin, M; von Stuelpnagel, C; Lotte, J; Staudt, M; Kluger, G
EPILEPSY BEHAV. 2011; 21(3): 282-284.
Originalarbeiten (Zeitschrift)
Frame-based vs frameless placement of intrahippocampal depth electrodes in patients with refractory epilepsy: a comparative in vivo (application) study.
Ortler, M; Sohm, F; Eisner, W; Bauer, R; Dobesberger, J; Trinka, E; Widmann, G; Bale, R;
Neurosurgery. 2011; 68(4): 881-887.
Originalarbeiten (Zeitschrift)
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID).
Tony, HP; Burmester, G; Schulze-Koops, H; Grunke, M; Henes, J; Kötter, I; Haas, J; Unger, L; Lovric, S; Haubitz, M; Fischer-Betz, R; Chehab, G; Rubbert-Roth, A; Specker, C; Weinerth, J; Holle, J; Müller-Ladner, U; König, R; Fiehn, C; Burgwinkel, P; Budde, K; Sörensen, H; Meurer, M; Aringer, M; Kieseier, B; Erfurt-Berge, C; Sticherling, M; Veelken, R; Ziemann, U; Strutz, F; von Wussow, P; Meier, FM; Hunzelmann, N; Schmidt, E; Bergner, R; Schwarting, A; Eming, R; Hertl, M; Stadler, R; Schwarz-Eywill, M; Wassenberg, S; Fleck, M; Metzler, C; Zettl, U; Westphal, J; Heitmann, S; Herzog, AL; Wiendl, H; Jakob, W; Schmidt, E; Freivogel, K; Dörner, T;
Arthritis Res Ther. 2011; 13(3):R75
Originalarbeiten (Zeitschrift)
Flexible dosing of adjunctive zonisamide in the treatment of adult partial-onset seizures: a non-comparative, open-label study (ZEUS).
Dupont, S; Striano, S; Trinka, E; Springub, J; Giallonardo, AT; Smith, P; Ellis, S; Yeates, A; Baker, G;
Acta Neurol Scand. 2010; 121(3):141-148
Originalarbeiten (Zeitschrift)
First European long-term experience with the orphan drug rufinamide in childhood-onset refractory epilepsy
Kluger, G; Haberlandt, E; Kurlemann, G; Ernst, JP; Runge, U; Schneider, F; Makowski, C; Boor, R; Bast, T
EPILEPSY BEHAV. 2010; 17(4): 546-548.
Originalarbeiten (Zeitschrift)
Complete removal of vagus nerve stimulator generator and electrodes.
Ortler, M; Unterhofer, C; Dobesberger, J; Haberlandt, E; Trinka, E;
J Neurosurg Pediatr. 2010; 5(2): 191-194.
Originalarbeiten (Zeitschrift)
Proliferative stimulation of the vascular Endothelin-1 axis in vitro and ex vivo by infection with Chlamydia pneumoniae.
Kern, JM; Maass, V; Rupp, J; Maass, M;
THROMB HAEMOSTASIS. 2009; 102(4): 74-53.
Originalarbeiten (Zeitschrift)
Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: First European experience
Kluger, G; Kurlemann, G; Haberlandt, E; Ernst, JP; Runge, U; Schneider, F; Makowski, C; Boor, R; Bast, T
EPILEPSY BEHAV. 2009; 14(3): 491-495.
Originalarbeiten (Zeitschrift)
Long-term use of zonisamide in refractory childhood-onset epilepsy.
Kluger, G; Zsoter, A; Holthausen, H;
Eur J Paediatr Neurol. 2008; 12(1): 19-23.
Originalarbeiten (Zeitschrift)
Reversal of pathological pain through specific spinal GABAA receptor subtypes.
Knabl, J; Witschi, R; Hösl, K; Reinold, H; Zeilhofer, UB; Ahmadi, S; Brockhaus, J; Sergejeva, M; Hess, A; Brune, K; Fritschy, JM; Rudolph, U; Möhler, H; Zeilhofer, HU;
Nature. 2008; 451(7176): 330-334.
Originalarbeiten (Zeitschrift)
N-terminal pro-brain natriuretic peptide (NT-proBNP) release in children with vagus nerve stimulation. A prospective case series.
Rauchenzauner, M; Haberlandt, E; Ortler, M; Tatarczyk, T; Laimer, M; Trinka, E; Luef, G;
J Neurol. 2008; 255(7): 980-985.
Originalarbeiten (Zeitschrift)
Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy.
Sonneveld, P; Hajek, R; Nagler, A; Spencer, A; Bladé, J; Robak, T; Zhuang, SH; Harousseau, JL; Orlowski, RZ;
Cancer. 2008; 112(7): 1529-1537.
Originalarbeiten (Zeitschrift)
Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone).
Zwick, C; Birkmann, J; Peter, N; Bodenstein, H; Fuchs, R; Hänel, M; Reiser, M; Hensel, M; Clemens, M; Zeynalova, S; Ziepert, M; Pfreundschuh, M;
Ann Hematol. 2008; 87(9):717-726
Originalarbeiten (Zeitschrift)
Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial.
Boeck, S; Weigang-Köhler, K; Fuchs, M; Kettner, E; Quietzsch, D; Trojan, J; Stötzer, O; Zeuzem, S; Lordick, F; Köhne, CH; Kröning, H; Steinmetz, T; Depenbrock, H; Heinemann, V;
Ann Oncol. 2007; 18(4): 74-51.
Originalarbeiten (Zeitschrift)
An open trial of levetiracetam for segmental and generalized dystonia.
Hering, S; Wenning, GK; Seppi, K; Poewe, W; Mueller, J;
Mov Disord. 2007; 22(11):1649-1651
Originalarbeiten (Zeitschrift)
Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
von Stuelpnagel, C; Holthausen, H; Kluger, G;
Eur J Paediatr Neurol. 2007; 11(6): 341-345.
Originalarbeiten (Zeitschrift)
Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: a nation-wide retrospective study in Austria.
Fiegl, M; Falkner, A; Hopfinger, G; Brugger, S; Zabernigg, A; Bauer, F; Haslbauer, F; Demirtas, D; Grossschmidt, P; Tatzreiter, G; Gastl, G; Greil, R;
CANCER. 2006; 107(10): 2408-2416.
Originalarbeiten (Zeitschrift)
Prospective trial on topotecan salvage therapy in primary CNS lymphoma.
Fischer, L; Thiel, E; Klasen, HA; Birkmann, J; Jahnke, K; Martus, P; Korfel, A;
Ann Oncol. 2006; 17(7):1141-1145
Originalarbeiten (Zeitschrift)
Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group
Bergmann, MA; Goebeler, ME; Herold, M; Emmerich, B; Wilhelm, M; Ruelfs, C; Boening, L; Hallek, MJ
HAEMATOL-HEMATOL J. 2005; 90(10): 1357-1364.
Originalarbeiten (Zeitschrift)
Levetiracetam in children with refractory epilepsy: A multicenter open label study in Germany
Opp, J; Tuxhorn, I; May, T; Kluger, G; Wiemer-Kruel, A; Kurlemann, G; Gross-Selbeck, G; Rating, D; Brandl, U; Bettendorf, U; Hartel, C; Korn-Merker, E
SEIZURE-EUR J EPILEP. 2005; 14(7): 476-484.
Originalarbeiten (Zeitschrift)
Levetiracetam in patients with refractory epilepsy: results of the SKATE trial in Austria, Germany and Switzerland.
Steinhoff, BJ; Trinka, E; Wieser, HG;
Seizure. 2005; 14(7):490-496
Originalarbeiten (Zeitschrift)
EKG abnormalities in children and adolescents with symptomatic temporal lobe epilepsy.
Mayer, H; Benninger, F; Urak, L; Plattner, B; Geldner, J; Feucht, M
Neurology. 2004; 63(2):324-328
Originalarbeiten (Zeitschrift)
Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma.
Hänel, M; Kröger, N; Sonnenberg, S; Bornhäuser, M; Krüger, W; Kroschinsky, F; Hänel, A; Metzner, B; Birkmann, J; Schmid, B; Hoffknecht, MM; Fiedler, F; Ehninger, G; Zander, AR;
Ann Hematol. 2002; 81(2): 96-102.
Originalarbeiten (Zeitschrift)
Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma.
Hänel, M; Kröger, N; Kroschinsky, F; Birkmann, J; Hänel, A; Herbst, R; Naumann, R; Friedrichsen, K; Ehninger, G; Zander, AR; Fiedler, F;
J Cancer Res Clin Oncol. 2001; 127(6):387-395
Originalarbeiten (Zeitschrift)
Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells.
Fechner, H; Wang, X; Wang, H; Jansen, A; Pauschinger, M; Scherübl, H; Bergelson, JM; Schultheiss, HP; Poller, W;
Gene Ther. 2000; 7(22): 1954-1968.
Originalarbeiten (Zeitschrift)
DIZE (dexamethasone, idarubicin, and continuous infusion of ifosfamide and etoposide): an effective and well-tolerated new regimen for patients with relapsed lymphoma.
Reiser, M; Schnell, R; Straub, G; Borchmann, P; Wilhelm, M; Ubelacker, R; Wörmann, B; Münch, R; Diehl, V; Engert, A;
Leuk Lymphoma. 1998; 31(3-4): 359-366.
Originalarbeiten (Zeitschrift)
A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin"s lymphoma.
Engert, A; Schnell, R; Küpper, F; Reiser, M; Engelhard, M; Wilhelm, M; Lathan, B; Baltes-Engler, S; Winterhalter, B; Scheulen, ME; Dederichs, B; Tesch, H; Wörmann, B; Diehl, V;
Leuk Lymphoma. 1997; 24(5-6): 513-522.
Originalarbeiten (Zeitschrift)
[Transjugular intrahepatic portasystemic shunt. A new therapeutic method in portal hypertension].
Tesdal, IK; Jaschke, W; Adamus, R; Georgi, M; Filser, T; Holm, E;
Tidsskr Nor Laegeforen. 1996; 116(8): 968-972.
Originalarbeiten (Zeitschrift)
Ifosfamide, mitoxantrone and etoposide (VIM) as salvage therapy of low toxicity in non-Hodgkin"s lymphoma.
Hopfinger, G; Heinz, R; Koller, E; Schneider, B; Pittermann, E;
Eur J Haematol. 1995; 55(4): 223-227.
Originalarbeiten (Zeitschrift)